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ABSTRACT: People are living longer, but lifespan increase does not coincide with a boost in health-span. Thus, 
improving the quality of life of older people is a priority. Centenarians reach extreme longevity in a relatively 
good health status, escaping or delaying fatal or strongly invalidating diseases. Therefore, studying processes 
involved in longevity is important to explain the biological mechanisms of health and well-being, since 
knowledge born from this approach can provide valuable information on how to slow aging. We performed the 
present study in a well characterized very homogeneous sample of 173 people from Western Sicily, to update 
existing literature on some phenotypic aspects of aging and longevity and to propose a range of values for older 
people. We classified 5 age groups, from young adults to centenarians, to understand the age and gender-
related variations of the different parameters under study. We collected anamnestic data and performed 
anthropometric, bioimpedance, molecular, haematological, oxidative, and hematochemical tests, adopting a 
multidimensional analysis approach. An important evidence of the present study is that there are differences 
related to both age and gender in several biomarkers. Indeed, gender differences seem to be still poorly 
considered and inadequately investigated in aging as well as in other medical studies. Moreover, we often 
observed comparable parameters between young and centenarians rather than non-agenarians and 
centenarians, hypothesizing a sort of slowdown, almost followed by a reversal trend, in the decay of systemic 
deterioration. The study of centenarians provides important indications on how to slow aging, with benefits for 
those who are more vulnerable to disease and disability. The identification of the factors that predispose to a 
long and healthy life is of enormous interest for translational medicine in an aging world.   
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People worldwide are living longer. Nonagenarians and 
centenarians, i.e., long living individuals (LLIs), are 
among the most rapidly growing segments of the 
population (www.who.int/ageing/publications/global_ 
health.pdf) [1]. According to United Nations estimates, 
in 2015 in the world there were nearly half a million 
centenarians, more than four times as many as in 1990 
(https://population.un.org/wpp/). Moreover, this growth 
is expected to accelerate. Projections suggest that there 




However, the increase in lifespan does not coincide 
with increase in health-span, i.e., the period of advanced 
life free from serious chronic diseases and disability [2]. 
Improving the quality of life of older people and 
slowing aging is becoming a priority due to the 
continuous increase in the number of this population [3]. 
This makes the studies of the processes involved in 
longevity of great importance. Beyond the study of age-
related diseases, it is possible to follow another 
approach, called positive biology, investigating the 
causes of positive phenotypes to explain the biological 
mechanisms of health and well-being. The best example 
of a positive phenotype is represented by centenarians, 
i.e., people living 100 years or more, who reach extreme 
longevity in a relatively good health status, escaping 
fatal or strongly invalidating diseases lifelong [4]. The 
knowledge born from this approach could allow us to 
modulate the aging rate by providing valuable 
information on how to slow aging.  
Naturally, it is not unexpected that centenarians 
might be frail, and that definition of their health status is 
methodologically difficult [2]. Reaching the age of 100, 
per se, does not necessarily indicate successful aging [5]. 
At this regard, three distinct morbidity profiles have 
been described, exploring the timing of most common 
age-related diseases in a sample of centenarians: the 
“escapers’’, who do not succumb to any age-related 
diseases; the “delayers’’, who postpone the onset of age-
related diseases; and the “survivors’’, who outlived with 
disease [6].  
Recently, in Southern Europe, it has shown that 
27.1% of the centenarian population could be labelled as 
“survivors”, 26.5% as “delayers”, and 46.4% as 
“escapers” [7]. On the other hand, centenarians appear to 
outlive the risks for many of the conditions that are 
common causes of death, such as cancer and myocardial 
infarction, slowing aging [8]. 
Thus, new studies to define some phenotypic aspects 
(i.e., physical and functional) of very old people and 
centenarians are needed. Whereas the genetics of 
longevity is largely analysed via multinational research 
programmes, few observations are known about peculiar 
phenotypic aspects of centenarians, i.e., anthropometric 
features or specific range for hematochemical and 
oxidative stress values [9].  
Thus, we performed a study in a well characterized 
very homogeneous sample of 173 people from Western 
Sicily, an Italian island in the centre of Mediterranean 
Sea, to update existing literature on some molecular and 
phenotypic aspects of aging and longevity and to 
propose a range of values for older people. We classified 
5 age groups, i.e., young adults, adults, older adults, 
nonagenarians, and centenarians, in order to understand 
the age and gender-related variations of the different 
parameters under study. We grouped the last two classes 
as LLIs. We collected anamnestic data and performed 
anthropometric, bioimpedance, molecular, 
haematological, oxidative, and Hematochemical tests, 
adopting a multidimensional analysis approach.  
 
MATERIALS AND METHODS  
 
Study design, participants and anamnestic data 
 
A total of 173 subjects of European ancestry were 
enrolled in Western Sicily within the project “Discovery 
of molecular and genetic/epigenetic signatures 
underlying resistance to age-related diseases and 
comorbidities (DESIGN, 20157ATSLF)”, funded by the 
Italian Ministry of Education, University and Research, 
from June 2017 to March 2020. The population was 
divided in five age groups, i.e., young adults (29 
subjects, age range 18-39 years old), adults (40 subjects, 
age range 40-64 years old), older adults (54 subjects, age 
range 65-89 years old), nonagenarians (27 subjects, age 
range 90-99 years old), and centenarians (23 subjects, 
age range 100-111 years old). We selected healthy 
people, considering the age physiological deterioration 
of organs and systems, including deafness, visual 
problems, and if they have no more than one invalidating 
condition. Moreover, we included cognitive-performant 
individuals only (although not completely). Thus, we 
excluded people with chronic invalidating diseases, such 
as neoplastic and autoimmune ones, as well as with acute 
disease, such as infectious, and with severe dementia. 
The majority of recruited subjects signed an informed 
consent before the enrolment. For three subjects, the 
caregiver provided for it, due to the visual problems of 
the participants. 
To respect privacy, everyone was identified with an 
alphanumeric code and the data were managed using a 
database accessible exclusively by researchers involved 
in the project. The study protocol, conducted in 
accordance with the Declaration of Helsinki and its 
amendments, was approved by the Ethic Committee of 
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Palermo University Hospital (Nutrition and Longevity, 
No. 032017). 
The enrolment was conducted at University of 
Palermo for young adults, adults, and older adults using 
social networks and word of mouth, whereas was 
conducted at home for nonagenarians and centenarians. 
This last procedure was chosen because of the 
difficulties for LLIs to go to our ambulatory. Most of our 
population of LLIs lived in small villages (most of them 
in the Madonie Mountains) with their family, so not in a 
big city, and in any case, they cannot drive and need a 
caregiver. For the recruitment of this group, we 
proceeded asking municipalities or general practitioners 
for the list of LLIs. Thereafter, contacting the family by 
a phone call to verify the consensus at participating in 
the study and the presence or absence of the inclusion 
and exclusion criteria, respectively. This kind of 
recruitment presents several limitations linked to the 
time and budget expenditure related to the home visit, 
often in the countryside that is difficult to reach from the 
town. But the advantage of home visit is to avoid any 
possible stress for LLIs and the possibility to study the 
context of living.  
A team composed by demographers, biologists and 
physicians from University of Palermo administered to 
the participants a detailed questionnaire to collect 
demographic, clinical, and anamnestic data of interest as 
well as functional and cognitive information (see 
Supplementary Material). The questionnaire includes 
nine sections: main pathologies, drugs and smoking, 
cognitive status such as mini-mental state examination 
(MMSE), geriatric depression scale (GDS), activities of 
daily living (ADL), instrumental activity of daily living 
(IADL), sleep, and eating habits. The maximum MMSE 
score is 30 points. A score under 18 suggests severe 
dementia, 18 to 25 suggests moderate to mild dementia, 
26 to 30 indicate normal cognitive ability. About GDS, 
we used the 15-items version, so the short one. The 
scores suggest respectively, 3±2 no depression, 7±3 mild 
depression, 12±2 severe depression. The MMSE, GDS, 
IADL, and ADL questionnaire sections were 
administered to LLIs only (for the Questionnaire see 





Concerning eating habits, we collected data by an 
already used food frequency questionnaire [12,13]. 
Overnight fasting blood samples were obtained in 
the morning. The blood was collected in specific tubes 
containing EDTA or without additives to separate 
plasma, serum, and blood cells. Hematochemical and 
haematological tests were performed immediately. 
Serum and plasma were obtained after centrifugation and 
genomic DNA was extracted from leukocytes with a 
commercial kit. These samples were rapidly frozen and 
stored at -80°C for further analyses. 
 
Anthropometric and bioimpedance parameters 
 
Anthropometric measures, including body weight and 
height, were performed with light dresses and barefoot 
and used to calculate the body mass index (BMI). The 
bioelectrical impedance analysis (BIA), that uses a 
single-frequency approach, was performed in the supine 
position. For the tetrapolar measurement, four skin 
electrodes were applied, one pair on the back of the hand 
and the other pair on the back of the ipsilateral foot. On 
the hand, there were placed one on the 
metacarpophalangeal joint of the third finger (injector 
electrode) and the other on the radio-ulnar joint (sensor 
electrode). On the foot, they were placed one on the 
metatarsophalangeal joint of the third toe (injector 
electrode) and the other on the tibio-tarsal joint (sensor 
electrode). The BIA device used was a portable Akern 
BIA 101 more suitable for at home visit, applying an 
alternating electrical current of 50 kHz (800 µA), not 
dangerous for tissues. The resistance, which reflects the 
volume of the water compartment, and the reactance, 
which is proportional to the cell mass in the body, both 
(in Ohm), and the phase angle (PhA, which indicates the 
relationship between resistance and reactance) were 
reported. PhA is a linear method of measuring the 
relationship between electric resistance and reactance 
and is an indicator of cell membrane functionality and of 
water compartment volume. The arc tangent value of the 
ratio of reactance versus electric resistance provides PhA 
values by BodygramPlus 1.1.4.4 software. The working 
principles, applications, merits, and demerits of BIA 
have been discussed in detail in Foster and Lukaski as 
well as in Bera [14,15]. 
 
Molecular tests  
 
Relative telomere length (RTL) was determined at the 
Dana Farber/Harvard Cancer Center Genotyping & 
Genetics for Population Sciences Facility (Boston, MA, 
USA), using a modified, high-throughput version of the 
real-time quantitative (Rtq) PCR-based telomere assay 
that was run on the Applied Biosystems 7900HT 
Sequence Detection System (Foster City, CA). 15 ng of 
genomic DNA was required for the protocol. The 
average RTL was determined as the copy-number ratio 
between telomere repeats and a single-copy (36B4) 
reference gene (T/S Ratio, -ΔCt). Leukocyte RTL is 
reported as the exponentiated T/S ratio corrected for a 
reference sample.  
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Although this assay measures RTL, the T/S ratio 
highly correlates with absolute TL provided by Southern 
Blot (r = 0.68-0.85; p<0.001) [16,17].  
The single-nucleotide polymorphism (SNP) 
rs2802292 G-allele (G>T) of Forkhead box O3A 
(FOXO3A) gene was genotyped, using an amplification-
refractory mutation system-polymerase chain reaction 
(ARMS-PCR), adopting registered and validated primers 
(certified at World International Property Organization, 
on 18/02/2010, n.WO 2010/019519 A2). Three 
genotypes were analysed: GG, GT, and TT. The size 
separation was conducted using agarose gel 
electrophoresis (2%).  
 
Table 1. Anamnestic and bioimpedance parameters. 
 
 
Variable (unit of 
measurement) 
(a) Young adults 
(18-39 y.o.) 
N=29, M=13, W=16 
(b) Adults 
(40-64 y.o.) 
N=40, M=21, W=19 
(c) Older adults 
(65-89 y.o.) 
N=54, M=28, W=26 
(d) Nonagenarians 
(90-99 y.o.) 
N=27, M=9, W=18 
(e) Centenarians 
(100-111 y.o.) 










1 10.00 (70.00-140.00) 
   N=29, (108.28±14.96) 
   M=13, (113.85±16.85) 
   W=16, (103.75±11.90) 
1 30.00 (100.00-160.00) 
   N=40, (128.50±13.27) 
   M=21, (129.29±12.07) 
   W=19, (127.63±14.75) 
  1 40.00 (100.00-160.00) 
  N=54, (135.52±15.06) 
  M=28, (134.03±13.98) 







M=6, (133.33 ±23.59) 
W=17, (127.94 ±31.23) 
(a vs b, 
c,d,e) 









   N=40, (79.00±9.75) 
   M=21, (80.48±8.65) 
   W=19, (77.27±10.85) 
  75.00 (60.00-100.00) 
  N=54, (75.63±9.56) 
  M=28, (75.14±10.39) 






N=23, (69.56 ±20.66) 
M=6, (67.50 ±10.84) 
W=17, (70.29 ±23.41) 
ns ns ns ns 










  6.00 (2.50-10.00) 
  N=36, (6.29±1.47) 
  M=19, (6.42±1.62) 






N=16, (7.69 ±2.80) 
M=2, (7.25 ±3.89) 
W=14, (7.75 ±2.80) 






















N=22, (23.45 ±3.68) 
M=6, (25.76 ±3.25) 
W=16, (22.58 ±3.53) 
(a vs 
b,c,d) 
(c vs e) 





  620.00 (423.00-793.00) 
  N=29, (613.75±93.31) 
  M=13, (534.92±63.26) 
  W=16, (677.81±57.36) 
   556.00 (376.00-774.00) 
   N=39, (558.43±85.84) 
   M=20, (505.65±56.35) 
   W=19, (614.00±76.49) 
 560.00 (437.00-812.00) 
 N=54, (561.05±67.49) 
 M=28, (537.14±56.43) 






N=22, (614.36 ±75.58) 
M=6, (570.00 ±99.18) 
W=16, (631.00 ±60.30) 



















N=21, (31.85 ±7.15) 
M=6, (30.00 ±5.06) 
W=15, (32.60 ±7.87) 
(a vs 
b,c,d,e) 
(b vs d,e) 























N=21, (3.24 ±1.43) 
M=6, (3.05 ±0.52) 
W=16, (3.33 ±1.63) 
(a vs c,d,e) 
(b vs c,d,e) 
(a vs c,d,e) 
(b vs c,d,e) 
(c vs e) 
(a vs d,e) 
(b vs d,e) 
(c vs e) 
=0.01 
Abbreviations: y.o.=years old; N=total number of cases; M=men; W=women; SD=standard deviation; BMI=body mass index; Rz=resistance; 
Xc=reactance; PhA=phase angle. 
Data underlined are the median (min-max) of the total number of cases. Data between round brackets are mean values±SD.  
a, b, c, d and e indicate, respectively, young adults, adults, older adults, nonagenarians, and centenarians.  
The table shows the Pairwise comparisons between the different groups, i.e., a, b, c, d, and e stratified for gender. p-value≤0.05 is considered 
significant; ns=not significant. 
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Figure 1. Anamnestic and bioimpedance parameters. The figure shows the trend of mean values by class of ages 
and gender related to anamnestic and bioimpedance parameters depicted. Y-axis reports the mean values of the 
analysed biomarker, x-axis reported the age-class (for the acronyms see the Table 1). 
 




(a) Young adults 
(18-39 y.o.) 




N=40, M=21, W=19 
 
(c) Older adults 
(65-89 y.o.) 



















 1.04 (0.60-1.51) 
 N=38, (1.02±0.20) 
 M=21, (1.01±0.23) 
 W=17, (1.05±0.16) 
 0.94 (0.45-1.46) 
 N=52, (0.94±0.25) 
 M=28, (0.91±0.25) 
 W=24, (0.96±0.26) 
 0.90 (0.54-1.33) 
 N=19, (0.97±0.25) 
 M=8, (0.89±0.30) 
 W=11, (0.99±0.20) 
 0.79 (0.46-1.60) 
 N=20, (0.81±0.25) 
 M=5, (0.77±0.12) 
 W=15, (0.83±0.28) 
(a vs b, 
c,d,e) 






 (a) Young adults 
(18-39 y.o.) 
N=29, M=13, W=16 
(b) Adults 
(40-64 y.o.) 
N=40, M=21, W=19 
(c) Older adults 
(65-89 y.o.) 
N=54, M=28, W=26 
(d) Nonagenarians 
(90-99 y.o.) 
N=27, M=9, W=18 
(e) Centenarians 
(100-111 y.o.) 











G 25 (43%) 33 (41%) 41 (38%) 26 (48%) 17 (37%) 
ns 





ε2 5 (8%) 7 (9%) 7 (6%) 6 (11%) 6 (13%) 
ns ε3 49 (85%) 69 (86%) 93 (87%) 47 (87%) 39 (85%) 
ε4 4 (7%) 4 (5%) 8 (7%) 1 (2%) 1 (2%) 
Abbreviations: y.o.=years old; N=total number of cases; M=men; W=women; SD=standard deviation; RTL=relative telomere length; FOXO3A=Forkhead 
box O 3A; APOE= Apolipoprotein-E. 
Data underlined are the median (min-max) of the total number of cases. Data between round brackets are mean values±SD.  
a, b, c, d, and e indicate, respectively, young adults, adults, older adults, nonagenarians, and centenarians.  
The table shows the Pairwise comparisons between the different groups, i.e., a, b, c, d, and e stratified for gender. p-value≤0.05 is considered significant; 
ns=not significant. 
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Figure 2. Molecular tests. The figure shows the trend of mean 
values by class of ages and gender related to RTL. Y-axis 
reports the mean values of the analysed biomarker, x-axis 
reported the age-class (for the acronyms see the Table 2). 
 
The EzWayTM Direct ApoE Genotyping Kit 
(Komabiotech Inc) was used to analyse Apolipoprotein 
(Apo)E polymorphisms. The genotype was defined by 
the combination of three alleles ε2, ε3, and ε4. The 
primer mixture of ApoE genes was enabled to perform 
one-step multiplex ARMS-PCR. Six genotypes were 
analysed: ε2/ε2, ε2/ε3, ε3/ε3, ε3/ε4, ε4/ε4, and ε2/ε4. 
The size separation was conducted using agarose gel 




The blood sample collected in the EDTA tube of each 
patient was analysed at the Department of Laboratory 
Medicine, “P. Giaccone” University Hospital, Palermo, 
on a UniCel DxH 900 haematology analyser (Beckman 
Coulter, Inc).  
 
Oxidative stress parameters  
 
The evaluation of paraoxonase (PON), Trolox equivalent 
antioxidant capacity (TEAC), and malondialdehyde 
(MDA) was conducted at the Department of Biomedical 
Sciences, University of Sassari, Italy, as previously 
described [18,19].  
 
 




(unit of measurement, 
laboratory range 
(a) Young adults 
(18-39 y.o.) 
N=29, M=13, W=16  
(b) Adults 
(40-64 y.o.) 
N=40, M=21, W=19  
(c) Older adults 
(65-89 y.o.) 
N=54, M=28, W=26  
(d) Nonagenarians 
(90-99 y.o.) 
N=27, M=9, W=18  
(e) Centenarians 
(100-111 y.o.) 





























(a vs e) 




























(a vs  d,e) 
(b vs d,e) 
























































































































ns ns ns ns 
Abbreviations: y.o.= years old; N=total number of cases; M=men; W=women; SD=standard deviation; N/L=Neutrophils/lymphocytes ratio.  
Data underlined are the median (min-max) of the total number of cases. Data between round brackets are mean values±SD.  
a, b, c, d, and e indicate, respectively, young adults, adults, older adults, nonagenarians, and centenarians.  
The table shows the Pairwise comparisons between the different groups, i.e., a, b, c, d, and e stratified for gender. p-value≤0.05 is considered 
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The tests were carried out at the Department of 
Laboratory Medicine, “P. Giaccone” University 
Hospital, Palermo, according to standard procedures. C-
reactive protein (CRP) measurement was performed by 
immunoturbidimetry methods, uric acid (UA) by 
colorimetric test, and lipid parameters by enzymatic 
colorimetric test through Roche/Hitachi Cobas system. 
The concentration of serum low density lipoprotein 
(LDL) was calculated by using the Friedewald equation: 
LDL= [total cholesterol-high(H)DL-(triglycerides/5)]. 
Insulin resistance status was assessed as homeostasis 
model assessment of insulin resistance (HOMA Index) 
according to the following formula: [insulin (μU/mL)* 
glycaemia (mg/dL)]/405. Vitamin D was evaluated as 




Data are presented both as median, minimum, maximum 
values, and mean±standard deviation (SD). For 
continuous variables, the two ways Analysis of Variance 
(ANOVA) is used to test if gender, age or both of them 
as joint events (i.e., their interaction), produce an effect 
on the quantitative parameters. The Fisher test is 
considered to evaluate the significance of the results. For 
each statistically significant effect, we conduct a post-
hoc multiple comparison test using Bonferroni method. 
For categorical variables, we consider the chi-squared 
test or the Fisher exact test to compare differences 
between groups of age and for gender. All analyses were 
performed using Stata version 14.2 and all hypothesis 




Anamnestic and bioimpedance parameters  
 
Table 1 reports blood pressure, sleeping habits, 
anthropometric features (BMI), and BIA parameters, 
while the other anamnestic and clinical data reported 
below, especially about LLIs description, are not 
tabulated. Figure 1 depicts graphically the blood 
pressure, BMI, and BIA parameters according to classes 
of age.  
As expected, systolic but not diastolic blood 
pressure is increased in the adult group compared to that 
observed in young adults. No significant difference in 
sleep habits (hours/night) is observed between the groups 
[21].  
All LLIs are no smokers with a small percentage of 
former smokers (20%). The percentage of smokers is 
quite high in young adults and adults (32%). Concerning 
MMSE, it is noteworthy that the mean values +SD of 
LLIs group suggest moderate to severe dementia (non-
agenarians 18.10±5.8; centenarians 17.00±6.1), with no 
significant gender differences. Similar MMSE values 
(16.45+4.4) were obtained in a study conducted in a 
group of New York centenarians [22]. 
However, it must be considered that values are lower 
in people with poor levels of education and with 
compromised sense organs, in particular sight and 
hearing (data not shown). The mean GDS±SD score 
indicates that most nonagenarians (5.7±3.1) and 
centenarians (4.8±4.4) are not depressed or mildly 
depressed, with no significant gender differences. In a 
recent study performed in another South European 
population, the prevalence of depression in centenarians 
was 35% [23]. 
Concerning ADL (e.g., personal hygiene, dressing, 
toileting/continence, ambulating, and eating), most LLIs 
have a good degree of independence. Conversely, 
regarding IADL (e.g., food preparation, financial 
administration, housekeeping, use of telephone, and 
responsibility for own medication) almost all 
centenarians show a decrease in performing these 
activities in the last years before the interview. Again, 
these observations agree to Jopp et al. [22]. 
About eating habits, at the time of interview the diet 
of LLIs was not strictly adherent to Mediterranean 
pattern for some food choices (e.g., frequent 
consumption of sweets, sugar, eggs, and biscuits as well 
as no consumption of whole grain). Nonetheless, they 
partially followed the Mediterranean diet (MedDiet) 
when compared to the younger subjects and, during their 
childhood and adolescence. Indeed, at present LLIs often 
ate cereals, like pasta, extra virgin olive oil (EVOO), 
milk, fruits, and legumes, very rare assuming red and 
cured meat, and more frequently choosing white meat 
(like chicken) and bluefish. Instead, the younger 
participants showed low consumption of vegetables, high 
assumption of sweets and potatoes, and ate more red and 
cured meat, but their diet is quite rich in fruit, legumes, 
and EVOO.  
Regarding drug assumption, 71% of nonagenarians 
and 52% of centenarians are treated with anti-
hypertensive, diuretics, and antiplatelet agents, whereas 
18% of nonagenarians and 39% of centenarians are 
treated with anxiolytic ones. Sight or hearing deficits are 
present in 64% of nonagenarians and 70% of 
centenarians. 
Moreover, we observed a significant increase of 
BMI in all groups, except for centenarians when 
compared to values observed in young adults. 
Interestingly, the centenarian BMI values are 
significantly lower than values observed in older adults 
with no gender effect.  
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Lastly, the resistance values obtained from BIA are 
not significantly different between the various groups, 
including centenarians, except for young and older 
female adults. The reactance values are significantly 
decreased in all classes of age, including centenarians, 
when compared to values of young people. Centenarian 
measurements are also significantly lower than those 
observed in the remaining classes of age. The PhA 
parameters decrease in all older classes of age, i.e., older 
adults, nonagenarians, and centenarians when compared 
to young adults and adults, both on the whole and 
separately in men and women. Resistance, reactance and 





Table 2 depicts the results of molecular tests (i.e., RTL 
and SNPs of FOXO3A and APOE). The RTL mean 
value decreases from young to centenarians in the whole 
cohorts and in women, with a significant variability 
between men and women. However, nonagenarians 
show RTL values not significantly different from that 
observed in adults and older adults both in the entire 
population and in women. Figure 2 depicts graphically 






Figure 3. Hematological 
parameters. The figure 
shows the trend of mean 
values by class of ages and 
gender related to 
haematological parameters. 
Y-axis reports the mean 
values of the analysed 
biomarker, x-axis reported 
the age-class (for the 
acronyms see the Table 3). 
 






(a) Young adults 
(18-39 y.o.) 
N=29, M=13, W=16 
(b) Adults 
(40-64 y.o.) 
N=40, M=21, W=19 
(c) Older adults 
(65-89 y.o.) 
N=54, M=28, W=26 
(d) Nonagenarians 
(90-99 y.o.) 
N=27, M=9, W=18 
(e) Centenarians 
(100-111 y.o.) 





























(a vs d) 
(b vs d) 











   4136.50 (2819.20-5572) 
   N=52, (4127.14±691.30) 
   M=28, (4027.08±679.07) 
   W=24, (4243.90±701.4) 
   5042.30 (3710.70-5653) 
   N=26, (4921.37±452.95) 
   M=8, (4659.93±556.56) 
   W=18, (5037.57±357.35) 
   4309.10 (2967.70-5774) 
   N=20, (4246.99±713.19) 
   M=5, (4541.38±1004.34) 
   W=15, (4148.90±600.70) 
(a vs 
b,c,d,e) 
(b vs d) 
(c vs d) 






















ns ns ns 0.03 
Abbreviations: y.o.=years old; N=total number of cases; M=men; W=women; SD=standard deviation; PON=paraoxonase; TEAC=trolox equivalent 
antioxidant capacity; MDA=malondialdehyde.  
Data underlined are the median (min-max) of the total number of cases. Data between round brackets are mean values±SD.  
a, b, c, d, and e indicate, respectively, young adults, adults, older adults, nonagenarians, and centenarians.  
The table shows the Pairwise comparisons between the different groups, i.e., a, b, c, d, and e stratified for gender. p-value≤0.05 is considered 
significant; ns=not significant. 
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Concerning the allelic frequencies of FOXO3A G and 
T SNPs and APOE genotypes, no significant differences 
are observed between the various classes of age on the 
whole and when analysed according to gender. However, 
it is noteworthy the lower, although not significant, 
number of events related to ε4 allele in nonagenarians 




Table 3 depicts the values of red blood cells, 
hemoglobin, platelets, leukocytes, neutrophils, 
lymphocytes, and their ratio (neutrophils/lymphocytes, 
N/L). Figure 3 depicts graphically hematological 
parameters, according to classes of age.  
As expected, the values of red blood cells, 
hemoglobin and platelets are significantly different 
between men and women [24,25]. Both hemoglobin and 
red blood cells values are lower in LLIs when compared 
to other age classes. The platelets also decrease with age, 
but significance is only obtained comparing male young 
adults to nonagenarians. However, it is noteworthy the 
not significant increase of N/L ratio in older people 
compared to younger [26]. No significant differences are 
observed in the other parameters under study.  
Comparing to Japanese centenarians recruited over 
the past 20 years, the values of red blood cells, 
hemoglobin, leukocytes and platelets were respectively 
3.58+0.52, 5.7+0.7, 5.4+1.5 and 188+61, thus lower of 
the means of our centenarians but in the range [27]. 
 





(a) Young Adults 
(18-39 y.o.) 
N=29; M=13; W=16 
(b) Adults 
(40-64 y.o.) 
N=40; M=21; W=19 
(c) Older adults 
(65-89 y.o.) 
N=54; M=28; W=26 
(d) Nonagenarians 
(90-99) y.o. 
N=27; M=9; W=18 
(e) Centenarians 
(100-111) y.o. 





















































(b vs d,e) 
(c vs e) 



















































(a vs c) ns ns ns 














































(a vs c) 
 






Figure 4. Oxidative Stress 
Parameters. The figure shows the 
trend of mean values by class of 
ages and gender related to oxidative 
parameters. Y-axis reports the mean 
values of the analysed biomarker, x-
axis reported the age-class (for the 
acronyms see the Table 4). 
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Abbreviations: y.o.=years old; N=total number of cases; M=men; W=women; SD=standard deviation; TSH=thyroid-stimulating hormone; FT3=free 
triiodothyronine; FT4=free thyroxine; HOMA=homeostasis model assessment. 
HOMA index was calculated by the following formula: [insulin (μU/mL)*glycaemia (mg/dL)]/405. 
Data underlined are the median (min-max) of the total number of cases. Data between round brackets are mean values±SD.  
a, b, c, d, and e indicate, respectively, young adults, adults, older adults, nonagenarians, and centenarians.  










figure shows the trend 
of mean values by class 
of ages and gender 
related to endocrine 
parameters reports the 
mean values of the 
analysed biomarker, x-
axis reported the age-
class (for the acronyms 
see the table 5). 
Table 6. Hematochemical parameters: Liver parameters. 
 
    Variable 
 (unit  
of 
measurement) 
(a) Young Adults 
(18-39 y.o.) 
N=29; M=13; W=16 
(b) Adults 
(40-64 y.o.) 
N=40; M=21; W=19 
(c) Older adults 
(65-89 y.o.) 
N=54; M=28; W=26 
(d) Nonagenarians 
(90-99) y.o. 
N=27; M=9; W=18 
(e) Centenarians 
(100-111) y.o. 




 M W 
ALT  
(U/L, <41) 




















(a vs b) 
(b vs d,e) 






























ns ns ns ns 
GGT 
(U/L, 8-61) 






































































































(b vs d,e) 
(c vs d,e) 
ns ns <0.001 






















(a vs c,e) ns ns ns 
 
Abbreviations: y.o.=years old; N=total number of cases; M=men; W=women; SD=standard deviation; ALT=alanine transaminase; AST=aspartate 
transaminase; GGT=gamma-glutamil transferase. 
Data underlined are the median (min-max) of the total number of cases. Data between round brackets are mean values±SD.  
a, b, c, d, and e indicate, respectively, young adults, adults, older adults, nonagenarians, and centenarians.  
The table shows the Pairwise comparisons between the different groups, i.e., a, b, c, d, and e stratified for gender. p-value≤0.05 is considered significant; 
ns=not significant. 
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Figure 6. Hematochemical parameters: Liver parameters. The figure shows the trend of mean values by class of 
ages and gender related to liver parameters. Y-axis reports the mean values of the analysed biomarker, x-axis reported 










(a) Young Adults 
(18-39 y.o.) 
N=29; M=13; W=16 
(b) Adults 
(40-64 y.o.) 
N=40; M=21; W=19 
(c) Older adults 
(65-89 y.o.) 
N=54; M=28; W=26 
(d) Nonagenarians 
(90-99) y.o. 
N=27; M=9; W=18 
(e) Centenarians 
(100-111) y.o. 













































































ns ns ns <0.001 
Abbreviations: y.o.=years old; N=total number of cases; M=men; W=women; SD=standard deviation. 
Data underlined are the median (min-max) of the total number of cases. Data between round brackets are mean values±SD.  
a, b, c, d, and e indicate, respectively, young adults, adults, older adults, nonagenarians, and centenarians.  
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Figure 7. Hematochemical parameters: Iron parameters. The figure shows the trend of mean values by 
class of ages and gender related to iron parameters. Y-axis reports the mean values of the analysed 




Figure 8. Hematochemical parameters: Lipid parameters. The figure shows the trend of mean values 
by class of ages and gender related to lipid parameters. Y-axis reports the mean values of the analysed 
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Comparing to Japanese centenarians recruited over 
the past 20 years, the values of red blood cells, 
hemoglobin, leukocytes and platelets were respectively 
3.58+0.52, 5.7+0.7, 5.4+1.5 and 188+61, thus lower of 
the means of our centenarians but in the range [27]. 
 
Oxidative stress parameters 
 
In Table 4 are compared the mean values of PON, 
TEAC, and MDA. Figure 4 depicts graphically oxidative 
stress parameters, according to classes of age.  
PON significantly decreases from young to 
nonagenarians, with a not statistically significant 
decrease in centenarians. TEAC significantly increases 
from young to LLIs, although the values slightly 
decrease in centenarians in comparison to nonagenarians. 
The MDA does not show significant age-related 





The tables 5 to 10 show hematochemical parameters, 
depicted graphically in the Figures 5 to 10, according to 
classes of age.  
Concerning endocrine markers (Table 5; Fig. 5), 
FT3 is significantly lower in LLIs, whereas TSH and 
FT4 are not affected by age. No differences are observed 
for insulin and HOMA index as well as for glycaemia. 
About liver markers (Table 6; Fig. 6), ALT levels are 
significantly decreased both in female and male LLIs, so 
with a gender effect, whereas not significant differences 
are observed for AST and GGT. On the contrary, 
bilirubin and conjugated bilirubin show an age-related 
decrease in the whole population but significant from 
young to nonagenarian. Finally, albumin as well as total 
protein also show an age-related decrease. 
Regarding iron markers (Table 7; Fig. 7), only iron 
levels show a significant decrease in LLIs, whereas there 
is a significant sex heterogeneity for ferritin since its 
values are lower in females. 
Total cholesterol is not increased in LLIs when 
compared to other age groups, whereas triglycerides 
raise in nonagenarians only. In centenarians, HDL is not 
significantly different from values observed in all 
groups, whereas nonagenarians show lower levels. LDL 
levels of LLIs are not significantly different from those 
observed in young people. Adult and older people 
display, instead, levels significantly higher than those 
observed in young. No gender effect is registered (Table 
8; Fig. 8). 
As regards bone markers (Table 9; Fig. 9), in women 
there is a very significant age- and gender-related 
increase of osteocalcin. ALP shows a significant age-
related increase, mostly in nonagenarian females, 
whereas calcium is significantly decreased in LLIs when 
compared to young adults and adults. Also, vitamin D 
levels are significantly decreased in LLIs when 
compared to young and adult groups. No effect of gender 
is observed. Magnesium is not significantly different 
between age groups and gender.  
There is a significant increment of urea and 
creatinine in LLIs, whereas uric acid (UA) is 
unmodified, although there is a significant gender 
heterogeneity for UA since its values are lower in 
women. Lastly, in LLIs CRP is increased when 
compared to young and adult age groups but significance 





(a) Young Adults 
(18-39 y.o.) 
N=29; M=13; W=16 
(b) Adults 
(40-64 y.o.) 
N=40; M=21; W=19 
(c) Older adults 
(65-89 y.o.) 
N=54; M=28; W=26 
(d) Nonagenarians 
(90-99 y.o.) 
N=27; M=9; W=18 
(e) Centenarians 
(100-111 y.o.) 
N=23; M=6; W=17 








































































(b vs d) 
(c vs d) 























(a vs b,c) 
(b vs d,e) 








Abbreviations: y.o.=years old; N=total number of cases; M=men; W=women; SD=standard deviation; HDL=high density lipoprotein; LDL=low density 
lipoprotein. 
Data underlined are the median (min-max) of the total number of cases. Data between round brackets are mean values±SD.  
a, b, c, d, and e indicate, respectively, young adults, adults, older adults, nonagenarians, and centenarians.  
The table shows the Pairwise comparisons between the different groups, i.e., a, b, c, d, and e stratified for gender. p-value≤0.05 is considered significant; 
ns=not significant. 
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was attained only comparing the young population to 
nonagenarians (Table 10; Fig. 10).  
 
 





(a) Young Adults 
(18-39 y.o.) 
N=29; M=13; W=16 
(b) Adults 
(40-64 y.o.) 
N=40; M=21; W=19 
(c) Older adults 
(65-89 y.o.) 
N=54; M=28; W=26 
(d) Nonagenarians 
(90-99 y.o.) 
N=27; M=9; W=18 
(e) Centenarians 
(100-111 y.o.) 
N=23; M=6; W=17 
Age 
Interaction Gender 























(a vs d) 
(b vs 
d,e) 
(c vs d) 
ns 
(a vs  
d,e) 
(b vs d,e) 
















































































































ns ns ns 
 
Abbreviations: y.o.=years old; N=total number of cases; M=men; W=women; SD=standard deviation; ALP=alkaline phosphatase. 
Data underlined are the median (min-max) of the total number of cases. Data between round brackets are mean values±SD.  
a, b, c, d, and e indicate, respectively, young adults, adults, older adults, nonagenarians, and centenarians.  





Figure 9. Hematochemical parameters: Bone parameters. The figure shows the trend of mean values by class of ages 
and gender related to bone parameters. Y-axis reports the mean values of the analysed biomarker, x-axis reported the 
age-class (for the acronyms see the table 9).   
 Aiello A., et al                                                                    Molecular and phenotypic parameters in aging and longevity 




Epidemiological data from various populations clearly 
suggest that centenarians represent an extraordinary and 
informative model for identifying the mechanisms 
responsible for healthy aging, although in most studies 
the genetic, demographic and phenotypic characteristics 
of longevity are discussed separately [7,22,28-31]. 
However, longevity is a complex trait due to the 
interactions of numerous genetic and environmental 
factors. Therefore, it is necessary to analyse the 
centenarians with a multidimensional approach, trying to 
consider different aspects at the same time, as performed 
in the present study [32]. 
We report anamnestic, anthropometric, molecular, 
haematological, oxidative, and hematochemical data of a 
homogeneous population of Sicilian centenarians and 
nonagenarians studied together with young adults, adults 
and older adults to have an adequate and matched 
number of controls. The information reported should be 
useful to understand the mechanisms that allow us to 
reach an advanced age in acceptable health conditions 
and to provide information on the reference ranges in 
older adults and LLIs, taking into account the gender. 
 
Regarding anamnestic data, analysing LLIs diet, it is 
not closely adherent to the traditional MedDiet even if it 
is rich in bioactive foods such as fruit, vegetables, 
legumes, and EVOO and poor in red meat, so it is an 
anti-inflammatory diet [33-35]. It is noteworthy that 
control of inflammation is a property of the slow-aging 
diets able to slow the ageing process, delaying or 
preventing a range of chronic age-related diseases [36]. 
These diets are characteristics of people living in Blue 
Zones, regions of the world where a higher than usual 
number of people live much longer than average, 
becoming centenarians [37-40]. From the Sixties, the 
consumption of meat, fish, fats and sugars has 
significantly increased in Southern Italy, while the 
consumption of whole cereals and vegetables has 
decreased. It is, therefore, likely that during this 
nutritional transition there was a change in the diet of the 
LLIs, as in the rest of the Italians [41]. Thus, the LLIs of 
our cohort adhered to the MedDiet at a young age for 
food shortages rather than choice. Necessarily, the 
nutritional options were strictly seasonal and composed 
by local products only, so rich in nutraceuticals, and the 
amount of food was sufficient but never excessive, i.e., a 
kind of calorie restriction, well known for its pro-
longevity effect [42]. These eating habits could affect 
ability to achieve extreme longevity through epigenetic 
modifications [33,41,43,44]. Concerning the other age 
groups, our results agree with a survey performed on 
3,090 Sicilians that assessed low to moderate adherence 
to the traditional dietary patterns, particularly in the 
younger segment of Sicilian population [45]. 
Table 10. Hematochemical parameters: Catabolic and inflammatory parameters. 
 
Variable 
(unit of measurement) 
(a) Young Adults 
(18-39 y.o.) 
N=29; M=13; W=16 
(b) Adults 
(40-64 y.o.) 
N=40; M=21; W=19 
(c) Older adults 
(65-89 y.o.) 
N=54; M=28; W=26 
(d) Nonagenarians 
(90-99 y.o.) 
N=27; M=9; W=18 
(e) Centenarians 
(100-111 y.o.) 
N=23; M=6; W=17 
Age 
Interaction Gender 























(a vs d,e) 
(b vs d,e) 
(c vs d,e) 























(a vs d,e) 
(b vs d,e) 
(c vs d,e) 














W=26, (4.64±1. 26) 








ns ns ns <0.001 





















(a vs d) ns ns ns 
 
Abbreviations: y.o.=years old; N=total number of cases; M=men; W=women; SD=standard deviation; CRP=C-reactive protein. 
Data underlined are the median (min-max) of the total number of cases. Data between round brackets are mean values±SD.  
a, b, c, d, and e indicate, respectively, young adults, adults, older adults, nonagenarians, and centenarians.  
The table shows the Pairwise comparisons between the different groups, i.e., a, b, c, d, and e stratified for gender. p-value≤0.05 is considered 
significant; ns=not significant. 
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About the other aspects of lifestyle of these Sicilian 
LLIs, Accardi et al., have reported that longevity mostly 
concerns people living in small villages, without 
pollution, likely because of different working conditions, 
different lifestyles, i.e., reduced smoking and alcohol 
abuse and an anti-inflammatory diet [46]. Longevity is 
observed particularly in small municipalities because 
individuals with greater access to social support and 
family networks have better health care and lower levels 
of mortality, particularly when adult daughters are 
present. Most of our LLIs live on the mountains in multi-
storey homes, so throughout their life they are constantly 
in physical exercise. Indeed, it was demonstrated the 
positive association between increased levels of physical 
activity, a feature of the lifestyle of Blue Zone also, and 
improved health in older adults [40,47]. 
In relation to BMI, usually centenarians are thought 
to be underweight but, in our cohort, overall they show 
BMI not significantly different from values observed in 
young adults and lower than those observed in older 
adults. It is noteworthy that the values and the range are 
almost like those observed in a recent study of a large 
number of Portuguese centenarians [48]. These data are 
interesting considering that underweight and overweight 
conditions are unfavourable for longevity. This is the so-
called obesity paradox that implies an inverse correlation 
between BMI and mortality, as demonstrated by several 
studies, although it could also be related to a low 
specificity of BMI for this segment of population 
[49,50]. This last hypothesis is reinforced by the analysis 
of body composition. It demonstrates lower PhA values 
in all classes of old individuals, both in men and in 
women, with significant differences between the 
genders. Using the PhA values, we should deduce that, 
on average, the centenarians under study are sarcopenic. 
From a theoretical point of view, the PhA data are not 
surprising because it is known that the higher are the 
PhA values, the better is the health condition [51]. PhA 
decreases as the body cell mass is lowered. Furthermore, 
it depends on extracellular water with inverse 
proportionality. A lower PhA appears to be compatible 
with cell death or a breakdown of the selective 
permeability of the cell membrane, in accordance with 
oedema. BIA specifically assesses hydration in any 
condition (clinical and otherwise) and is a suitable 
method for nutritional assessment. However, current 
models have been developed from analysis in healthy 
younger subjects. Therefore, as recently discussed, a 
note of caution should be added as it may not be fully 
suitable for the centenarian population likely suffering 
massive fluids and electrolysis changes [12,52]. 
Telomeres undergo shortening with each mitotic 
division and this process is modulated by inflammation 
and oxidative stress. The short telomeres therefore 
represent a marker of cumulative burden of inflammation 
and oxidative stress. Indeed, they are associated with a 
higher risk of all-cause mortality while individuals 










parameters. The figure 
shows the trend of 
mean values by class of 
ages and gender related 
to catabolic and 
inflammatory 
parameters. Y-axis 
reports the mean values 
of the analysed 
biomarker, x-axis 
reported the age-class 
(for the acronyms see 
the table 10). 
 Aiello A., et al                                                                    Molecular and phenotypic parameters in aging and longevity 
Aging and Disease • Volume 12, Number 5, October 2021                                                                              17 
 
our sample, LLIs women have RTL not significantly 
different from that of older women. Moreover, the RTLs 
of two semisuper- and super-centenarian sisters fit in the 
average plus/minus standard deviation of 60-69 Sicilian 
women [12]. 
The evolutionary conserved transcription factor 
FOXO3A plays important regulatory roles in 
insulin/insulin-like growth factor signalling. The 
activation of this pathway by a diet rich in proteins and 
refined sugars suppresses its transcription [54]. The 
FOXO3A rs2802292 is associated with longevity in 
different populations, likely due to an increased 
expression of FOXO3A involved in homeostatic 
responses [55]. However, in our cohorts we do not 
observe an association with longevity, likely for the 
small sample size although the MedDiet strictly followed 
at a young age by our LLIs might be responsible for the 
lack of association. 
ApoE ε4 allele is a risk factor for the onset of 
Alzheimer's and cardiovascular diseases. Hence, it has a 
deleterious effect on longevity. The ε3 allele is a neutral 
allele, whereas ε2 is the allele thought to promote 
longevity [56]. In our LLIs, we did not observe an 
association of ε2 with longevity, but we found the lowest 
percentage of ε4. These results are consistent with a 
recent analysis that shows that in South Italy there is a 
weaker protective effect of ε2 and no detrimental effect 
of ε4, suggesting that the MedDiet strictly followed in 
South Italy at a young age by the generations under 
study is responsible, as above, for that difference [56]. 
Heme synthesis declines with age and its deficiency 
should be responsible for the lower levels of red blood 
cells and hemoglobin in LLIs, although some underlying 
pathological conditions might be involved. The lower 
values of platelets in the LLIs, when compared to the 
young adults, are likely due to the slowing down of the 
haematopoietic system activity during aging [57-59]. 
No significant differences are observed in leukocyte 
counts. Neutrophils, traditionally considered as a 
component of acute inflammation, also increase in 
chronic age-related diseases, as atherosclerosis [60]. 
Lymphocytes are involved in immune responses and 
their age-related changes are represented by a different 
ratio of their subsets rather than an age-related decrease. 
N/L is an emerging inflammatory marker because it 
combines the predictive power of both decreased 
lymphocyte and increased neutrophil counts [26]. In 
people aged 55 years and older, this ratio is associated 
with mortality [61]. However, the not significant 
increase of N/L ratio observed in LLIs (and to a lesser 
extent in older adults) is related to the low-grade 
inflammatory status of old people called “inflammaging” 
[62,63]. 
Aging is associated with an increase in pro-oxidant 
factors and a decrease in antioxidant mechanisms. 
Oxidative stress plays an important role in determining 
and maintaining the typical low-grade inflammation, in 
turn contributing to oxidative stress. However, in several 
groups of centenarians, some indexes of oxidative stress 
have been demonstrated to be lower than in older 
subjects [64]. In centenarians, PON units are not 
significantly different from those observed in young 
people. PON is an enzyme associated with HDL, 
believed to protect against the oxidation (ox-) of LDL, so 
protecting from the risk of coronary artery disease [65]. 
It is noteworthy that the value range of ox-LDL in these 
centenarians is lower than that observed in young people 
[66]. MDA, the main product of the polyunsaturated 
fatty acids peroxidation, is not significantly different 
between the groups. The range values of blood 
glutathione in these centenarians have been shown to be 
included in the value range of young people [66]. It is 
seemingly puzzling that the total antioxidant capacity is 
lower in young people than in the other groups and that 
the highest values are observed in nonagenarians. As 
suggested, the eating habits of adults and older people, 
more adherent to MedDiet than young people could 
contribute to our observations [67]. 
Concerning hematochemical values, FT3 are 
significantly lower in LLIs. This result agrees with data 
that clinical or latent hypothyroidism is rising in the 
older population. A lower activity of thyroid hormone, 
and, thus, a decreased basal metabolic rate lowering 
oxidative metabolism might reduce DNA damage due to 
reactive oxygen species [68].  
Regarding the decrease of ALT values, ALT levels 
decrease with age in both men and women independent 
on metabolic syndrome components, adiposity signalling 
biomarkers, and other commonly used liver function 
tests, although further studies are needed to understand 
the mechanisms responsible for its decline [69]. In our 
cohort, bilirubin shows a significant age-related 
decrease, except in centenarians. In contrast, the study of 
Boland et al., reveals that serum bilirubin levels 
modestly increase with age and that elevated bilirubin in 
older individuals is not associated with improved 
survival, as previously reported in middle-aged 
populations [70]. Albumin (and total proteins) levels are 
decreased in LLIs in agreement with results obtained in 
several centenarian studies. It has been used as a 
biochemical indicator of nutritional status. However, 
albumin levels are more a reflection of overall chronic or 
acute disease burden than of nutritional status, in 
particular their decrease is also linked to inflammatory 
status, as negative acute phase protein [71]. 
Iron deficiency anaemia is prevalent in older people, 
particularly after the age of 80. So, the significant serum 
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level decrease in our LLIs is not surprising because 
chronic inflammation of older people makes the 
measurement of iron status difficult. Levels of 
circulating hepcidin, elevated in response to 
inflammation, are likely responsible for systemic iron 
depletion [66,63,72]. Other contributory factors could be 
the scarcity of iron content in the diet and the assumption 
of some medications, such as aspirin [73].  
Our data on cholesterol, LDL and HDL, as well as 
triglycerides are substantially in line with the literature 
data. Indeed, studies indicate that total, LDL and HDL 
cholesterol levels of centenarians are either not different 
or lower than their older adult controls. Instead, 
triglycerides are like healthy older adult controls [71].   
Regarding osteocalcin, an osteoblast-specific 
secreted protein expressed by mature osteoblasts, the 
observed increase is not surprising because it is used in 
clinical practice and in research as a marker of bone 
turnover [74]. The same meaning should have the age-
related increase in ALP mostly due to female gender 
[75]. The low levels of calcium observed in LLIs are 
likely linked to low levels of vitamin D due to 
inadequate consumption or exposure to sunlight [76,77]. 
As expected, there is a significant increase of urea 
and creatinine values in LLIs, according to age-related 
progressive reduction of kidney functionality [59,78]. 
CRP is an acute phase reactant that responds rapidly 
to tissue injury, infection and inflammation. Not 
surprisingly, significantly higher concentrations of the 
protein are reported for LLIs as compared with their 
controls (although the increase was not significant in 
centenarians), in the present study, as well as in several 
other reports [71]. 
The decrease of albumin levels, the increase of CRP 
levels as well as not significant increase of N/L ratio in 
LLIs are witnesses of the chronic inflammatory state of 
the LLIs. In addition, our LLI cohort has been shown to 
present the kynurenine/tryptophan (Kyn/Trp) ratio, a 
valuable marker for the rate of inflammaging, higher 
than in all other age-groups [66,79]. 
Inflammaging is a process observed in any older 
subjects. However, centenarians seem to be equipped 
with gene variants that optimize the balance between 
pro- and anti-inflammatory molecules, minimizing the 
detrimental effect of inflammaging [80]. The increased 
plasma levels of pro-inflammatory molecules should be 
counter-balanced by a higher level of anti-inflammatory 
molecules. LLIs belonging to this cohort displayed an 
increased enzymatic activity of the extracellular 
proteinase matrix metalloproteinase 2 known to regulate 
intercellular communication, including inflammation 
[81]. The value range of microRNA miR-223-5p, 
involved in the control of inflammation, in the 
centenarians under study is higher than that observed in 
young and adult people [66,82]. These two observations 
suggest a possible epigenetic modulation, with anti-
inflammatory effects, that confer protection against 
tissue damage [83]. 
An important evidence of the present study is that 
there are differences related to both age and gender in 
several biomarkers. In fact, despite their biomedical 
relevance, gender differences seem to be still poorly 
considered and inadequately investigated in medical 
studies including aging [84,85]. 
Moreover, it is to note that often we observed 
comparable parameters between young and centenarians 
rather than nonagenarians and centenarians, 
hypothesizing a sort of slowdown in the decay of 
systemic deterioration.  
The small sample size is a limitation of the present 
study, mostly regarding the molecular tests, although 
performed in a very homogeneous population. Thus, due 
to the small number of individuals studied, the data 
concerning the various biomarker values should be 
utilized and validated in further studies. 
Much remains to be learned about the prognostic 
significance of these biomarkers and their possible 
treatment. Particularly, if it makes sense to treat the pro-
inflammatory state of LLIs. Would such treatment lead 
to improvements in physical, cognitive and/or functional 
state of LLIs? How might knowledge of the RTL be used 
to decrease morbidity and delay mortality in late life? 
Addressing these and other questions regarding the 
interpretation of biomarkers in LLIs is increasingly 
important as many people cross the 90 years. The 
identification of the factors that predispose to healthy life 
in a relatively good health status, i.e., a longevity 
signature, is of enormous interest for translational 
medicine in an aging world.   
A long life in a healthy, vigorous, youthful body has 
always been one of humanity’s greatest dreams. Slow the 
ageing process means not only to delay or avoid the 
onset of age-related disease but also to extend the year of 
life free from the need of care and being independent, 
with a direct effect on the cost of healthcare. The 
possibility to target aging directly, instead of treating 
age-related pathologies could be of great relevance to 
improve the quality of life worldwide and to guarantee a 
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